Open Access
ARTICLE
Update on the diagnosis and management of prostate cancer
Mark LaSpina, Gabriel P. Haas
Department of Urology, State University of New York, Upstate Medical University, Syracuse, New York, USA
Address correspondence to Dr. Gabriel P. Haas, Department
of Urology, State University of New York, Upstate Medical
University, 750 East Adams Street, Syracuse, New York
31210 USA
Canadian Journal of Urology 2008, 15(Suppl.4), 3-13.
Abstract
Early detection of prostate adenocarcinoma (prostate
cancer) through screening tests such as a serum prostatespecifi c antigen (PSA) test and a digital rectal examination
(DRE) enables primary care physicians and urologists to
offer patients a broader choice of treatments that are also
more likely to provide a cure. Whether men are being over
treated or over diagnosed through the widespread use of
screening tests remains controversial. This review aims to
provide general practitioners with a better understanding
of different prostate cancer tests that can be performed and
to help them decide which patients should be referred to a
urologist for an ultrasound-guided biopsy.
Keywords
prostate adenocarcinoma, early cancer detection, prostate-specifi c antigen, digital rectal exam
Cite This Article
APA Style
LaSpina, M., Haas, G.P. (2008). Update on the diagnosis and management of prostate cancer. Canadian Journal of Urology, 15(Suppl.4), 3–13.
Vancouver Style
LaSpina M, Haas GP. Update on the diagnosis and management of prostate cancer. Can J Urology. 2008;15(Suppl.4):3–13.
IEEE Style
M. LaSpina and G.P. Haas, “Update on the diagnosis and management of prostate cancer,” Can. J. Urology, vol. 15, no. Suppl.4, pp. 3–13, 2008.
Copyright © 2008 The Canadian Journal of Urology.